A group of biotech investors is scheduled to meet with members of a congressional commission tasked with maintaining US competitiveness in biotechnology and protecting national security interests. The meeting comes as concerns grow over China's expanding influence in the life sciences sector.
The congressional commission has been specifically charged with addressing the challenge of keeping the United States competitive in biotechnology while safeguarding national security priorities. This mandate reflects growing awareness of biotechnology's strategic importance to both economic competitiveness and national defense.